1192313-58-8

Basic information

• Product Name: ethyl 3-[(3-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}propyl)oxy]-1-{2-[4-fluoro-3-(trifluoromethyl)phenyl]-2-oxoethyl}-1-H-pyrazole-5-carboxylate
• Synonyms: ethyl 3-[(3-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}propyl)oxy]-1-{2-[4-fluoro-3-(trifluoromethyl)phenyl]-2-oxoethyl}-1-H-pyrazole-5-carboxylate
• CAS NO: 1192313-58-8
• Molecular Weight: 532.608
• Mol File: 1192313-58-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: ethyl 3-[(3-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}propyl)oxy]-1-{2-[4-fluoro-3-(trifluoromethyl)phenyl]-2-oxoethyl}-1-H-pyrazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-[(3-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}propyl)oxy]-1-{2-[4-fluoro-3-(trifluoromethyl)phenyl]-2-oxoethyl}-1-H-pyrazole-5-carboxylate(1192313-58-8)
• EPA Substance Registry System: ethyl 3-[(3-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}propyl)oxy]-1-{2-[4-fluoro-3-(trifluoromethyl)phenyl]-2-oxoethyl}-1-H-pyrazole-5-carboxylate(1192313-58-8)

Safety Data

• Hazardous Substances Data: 1192313-58-8(Hazardous Substances Data)

Upstream product

• 208173-24-4 1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone 
• 89031-84-5 3-(tert-butyldimethylsilyloxy)propyl bromide 
• 40711-33-9 ethyl 2,5-dihydro-5-oxo-1H-pyrazole-3-carboxylate 
• 537050-14-9 2-bromo-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethan-1-one 
• 1192313-21-5 ethyl 3-[(3-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}propyl)oxy]-1H-pyrazole-5-carboxylate 

Downstream Products

• 1192313-59-9 3-({6-[4-fluoro-3-(trifluoromethyl)phenyl]-4-oxo-4,5-dihydropyrazolo[1,5-a]pyrazin-2-yl}oxy)propyl acetate 

Relevant articles and documents

Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: Novel, potent, and selective series of Vasopressin1b receptor antagonists

Novel series of pyrrole-pyrazinone and pyrazole-pyrazinone have been identified as potent and selective Vasopressin1b receptor antagonists. Exploration of the substitution pattern around the core of these templates allowed generation of compounds with high inhibitory potency at the Vasopressin1b receptor, including examples that showed good selectivity with respect to Vasopressin1a, Vasopressin2, and Oxytocin receptor subtypes.